Search results for "FUNGAL"

showing 10 items of 1116 documents

Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights

2017

Purpose of Review: The purpose of this study was to provide an overview and insights on important new concepts on untargeted antifungal treatment strategies, namely prophylaxis pre-emptive and empiric treatments for the management of invasive candidiasis (IC) in non-neutropenic critically ill patients. Recent Findings: Recently, clinical practice guidelines provided recommendation for the management of IC. However, results from recent trials and systematic reviews questioned the effect of untargeted antifungal treatment strategies, especially in terms of survival benefits in non-neutropenic patients, even with septic shock. Summary: Widespread use of untargeted antifungal treatment strategi…

Antifungalmedicine.medical_specialtyEmpiric treatmentmedicine.drug_classInvasive candidiasiBiology03 medical and health sciences0302 clinical medicineInvasive fungal infectionmedicine030212 general & internal medicineAntifungal treatmentMED/41 - ANESTESIOLOGIAIntensive care medicineCandida infectionCritically illCandidemia030208 emergency & critical care medicineInvasive candidiasismedicine.diseaseNon neutropenicClinical PracticeInvasive candidiasisInfectious DiseasesSystematic reviewTreatment strategyAntifungal treatment; Candida infection; Candidemia; Empiric treatment; Invasive candidiasis; Invasive fungal infectionEmpiric treatment
researchProduct

Itraconazole versus Fluconazole for Antifungal Prophylaxis

2004

Antifungalmedicine.medical_specialtyItraconazolebusiness.industrymedicine.drug_classmedicine.medical_treatmentGeneral MedicineHematopoietic stem cell transplantationGastroenterologyClinical trialTransplantationmedicine.anatomical_structureInternal medicineInternal MedicinemedicineBone marrowbusinessFluconazolemedicine.drugAnnals of Internal Medicine
researchProduct

Evidencia cientifica de la laserterapia en onicomicosis

2017

[Resumen] Objetivo: En los últimos años se ha extendido el tratamiento con láser como complemento del tratamiento de la onicomicosis. Existen diferentes publicaciones en relación a los distintos tipos de láser para el tratamiento de las onicomicosis, que contienen diversos resultados de eficacia. El presente trabajo recopila los resultados obtenidos en diferentes estudios con el fin de determinar la eficacia de esta terapia. Determinar la eficacia del tratamiento con laserterapia en casos de infecciones micóticas ungueales. Establecer el nivel de evidencia científica del tratamiento láser en infecciones fúngicas de las uñas. Método: Se realiza un trabajo de revisión mediante búsqueda biblio…

Antifungalmedicine.medical_specialtyNail Infectionmedicine.drug_classPopulationLáserNailUñasLaser therapyFongsOnicomicosisOnychomycosisMedicineeducationMycosiseducation.field_of_studyCo2 laserbusiness.industryLaser treatmentmedicine.diseaseDermatologiaDermatologySurgeryClinical trialbusiness
researchProduct

Pooled analysis of safety for micafungin

2008

Micafungin (MICA) is an efficacious antifungal treatment for life-threatening fungal infections [1-4].

Antifungalmedicine.medical_specialtyPediatricsmedicine.drug_classbusiness.industryMicafunginbacterial infections and mycosesCritical Care and Intensive Care Medicinestomatognathic diseasesPooled analysisInternal medicinePoster Presentationmedicinelipids (amino acids peptides and proteins)businessmedicine.drugCritical Care
researchProduct

What Is the Most Recent Evidence on the Prevention and Early Treatment of Invasive Fungal Infections in Nonneutropenic Critically Ill Patients?

2017

: Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care units. Candida species are the most important fungal pathogens and among the most frequent causes of infection in critically ill patients. Studies have evaluated the correlation between the onset of antifungal treatment and survival. However, definitive diagnosis of IFI is time-consuming in clinical practice. Antifungal prophylaxis and preemptive or empirical treatments are among therapeutic strategies to prevent or treat early fungal infections in selected patients. Recently, new evidence from randomized controlled trials and systematic reviews has been published. Moreover, new clinical p…

Antifungalmedicine.medical_specialtymedicine.drug_classFungal sepsisToxicologyCritical Care and Intensive Care Medicinelaw.invention03 medical and health sciencesHigh morbidityInvasive fungal infection0302 clinical medicineRandomized controlled triallawIntensive careMedicineAntifungal treatment030212 general & internal medicineIntensive care medicineCandida sppFungal sepsibusiness.industryCritically illPublic Health Environmental and Occupational Health030208 emergency & critical care medicineClinical PracticeAntifungal treatment; Candida spp; Fungal sepsis; Invasive fungal infectionInfectious DiseasesSystematic reviewFungal sepsisbusinessArchives of Clinical Infectious Diseases
researchProduct

Synthesis and structural elucidation of novel antifungal N-(fluorophenyl)piperazinyl benzoxaboroles and their analogues

2019

Abstract Series of novel N-(fluorophenyl)piperazine derivatives of phenylboronic compounds including benzoxaboroles, phenylboronic acids and phenylboronic methyl monoester have been obtained by facile synthetic methods starting from 2-formylphenylboronic acid. Molecular and crystal structures of those novel derivatives have been investigated by single crystal X-ray diffraction method. The Bond Valence Vector Model was used to describe strains in the boron coordination sphere. Microbiological activity of novel benzoxaboroles as well as their corresponding acid analogues against: A. niger, A. terreus, P. ochrochloron, C. tenuis and F. dimerum has been evaluated. The presence of heterocyclic b…

AntifungalorganoboronValence (chemistry)Coordination sphere010405 organic chemistryChemistrymedicine.drug_classphenylboronic acidantifungal activityOrganic ChemistrybenzoxaboroleCrystal structurepiperazine010402 general chemistry01 natural sciencesCombinatorial chemistryfluorophenyl0104 chemical sciencesAnalytical ChemistryInorganic Chemistrychemistry.chemical_compoundPiperazinemedicinePhenylboronic acidSpectroscopyJournal of Molecular Structure
researchProduct

Ag+ Complexes as Potential Therapeutic Agents in Medicine and Pharmacy

2019

Silver is a non-essential element with promising antimicrobial and anticancer properties. This work is a detailed summary of the newest findings on the bioinorganic chemistry of silver, with a special focus on the applications of Ag+ complexes and nanoparticles. The coordination chemistry of silver is given a reasonable amount of attention, summarizing the most common silver binding sites and giving examples of such binding motifs in biologically important proteins. Possible applications of this metal and its complexes in medicine, particularly as antibacterial and antifungal agents and in cancer therapy, are discussed in detail. The most recent data on silver nanoparticles are also summari…

Antifungalsilver nanoparticlesSilvermedicine.drug_classCancer therapyMetal NanoparticlesNanoparticleAntineoplastic Agents02 engineering and technologyPharmacology010402 general chemistry01 natural sciencesBiochemistrySilver(I) complexesSilver nanoparticleCoordination complexStructure-Activity RelationshipAnti-Infective AgentsCoordination ComplexesDrug DiscoverymedicineHumansAmino Acid SequenceAmino AcidsIonsPharmacologychemistry.chemical_classificationMolecular StructureChemistryOrganic Chemistryantibacterial and anticancer activity of Ag+021001 nanoscience & nanotechnologyCombinatorial chemistry0104 chemical sciencescysteine and methionine motifsMolecular Medicine0210 nano-technologyProtein BindingCurrent Medicinal Chemistry
researchProduct

The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen.

1997

A lambda gt11 cDNA library from Candida albicans ATCC 26555 was screened by using pooled sera from two patients with systemic candidiasis and five neutropenic patients with high levels of anti-C. albicans immunoglobulin M antibodies. Seven clones were isolated from 60,000 recombinant phages. The most reactive one contained a 0.9-kb cDNA encoding a polypeptide immunoreactive only with sera from patients with systemic candidiasis. The whole gene was isolated from a genomic library by using the cDNA as a probe. The nucleotide sequence of the coding region showed homology (78 to 79%) to the Saccharomyces cerevisiae TDH1 to TDH3 genes coding for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), …

Antigens FungalDNA ComplementaryGenes FungalMolecular Sequence DataBiologyMicrobiologystomatognathic systemCell WallComplementary DNACandida albicansmedicineHumansCloning MolecularCandida albicansFluorescent Antibody Technique IndirectMolecular BiologyGlyceraldehyde 3-phosphate dehydrogenaseAntibodies FungalAntiserumcDNA libraryCandidiasisAntibodies MonoclonalGlyceraldehyde-3-Phosphate Dehydrogenasesmedicine.diseasebiology.organism_classificationMolecular biologyCorpus albicansBlotting SouthernBiochemistryPolyclonal antibodiesAntigens Surfacebiology.proteinSystemic candidiasisGlycolysisResearch Article
researchProduct

Cloning and characterization of PRA1, a gene encoding a novel pH-regulated antigen of Candida albicans.

1998

ABSTRACT Candida albicans is an opportunistic fungal pathogen of humans. The cell wall of the organism defines the interface between the pathogen and host tissues and is likely to play an essential and pivotal role in the host-pathogen interaction. The components of the cell wall critical to this interaction are undefined. Immunoscreening of a lambda expression library with sera raised against mycelial cell walls of C. albicans was used to identify genes encoding cell surface proteins. One of the positive clones represented a candidal gene that was differentially expressed in response to changes in the pH of the culture medium. Maximal expression occurred at neutral pH, with no expression d…

Antigens FungalDNA ComplementaryMolecular Sequence DataReceptors Cell SurfaceMicrobiologyFungal ProteinsImmunoscreeningGene Expression Regulation FungalCandida albicansAmino Acid SequenceCloning MolecularCandida albicansMolecular BiologyGenePeptide sequencechemistry.chemical_classificationFungal proteinbiologyBase SequenceSequence Homology Amino AcidHydrogen-Ion Concentrationbiology.organism_classificationMolecular biologyCorpus albicansPhenotypeEukaryotic CellschemistryCell fractionationGlycoproteinJournal of bacteriology
researchProduct

Identification of a mannoprotein present in the inner layer of the cell wall of Saccharomyces cerevisiae.

1997

Cell wall extracts from the double-mutant mnn1 mnn9 strain were used as the immunogen to obtain a monoclonal antibody (MAb), SAC A6, that recognizes a specific mannoprotein--which we have named Icwp--in the walls of cells of Saccharomyces cerevisiae. Icwp runs as a polydisperse band of over 180 kDa in sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of Zymolyase extracts of cell walls, although an analysis of the secretory pattern of the mannoprotein shows that at the level of secretory vesicles, it behaves like a discrete band of 140 kDa. Immunofluorescence analysis with the MAb showed that Icwp lies at the inner layer of the cell wall, being accessible to the antibody on…

Antigens FungalDNA ComplementarySaccharomyces cerevisiae ProteinsGlycosylphosphatidylinositolsSaccharomyces cerevisiaeGenes FungalMolecular Sequence DataSaccharomyces cerevisiaeCalcofluor-whiteBiologyMicrobiologySerineCell wallFungal Proteinschemistry.chemical_compoundCell WallThreonineMolecular BiologyGel electrophoresisMembrane GlycoproteinsBase SequenceAntibodies MonoclonalTunicamycinbiology.organism_classificationMolecular biologycarbohydrates (lipids)Open reading frameMutagenesis InsertionalchemistryBiochemistryResearch Article
researchProduct